The research project “Radiolabeled Vectors in Nuclear Oncology” coded Ε12224 with a 5-year duration (2018-2023) is coordinated by Dr. T. Maina-Nock. It concerns a research cooperation of the Molecular Radiopharmacy team with Cyclotron Rotterdam BV, Erasmus, MC, Rotterdam, The Netherlands. The latter partner is also sponsoring these activities aiming at the development of new radiopharmaceuticals for cancer-targeting in human.